Pesquisas alternativas:
transoral lung » transformed lung (Expandir a Pesquisa)
cancer ready » cancer real (Expandir a Pesquisa), cancer renal (Expandir a Pesquisa)
transl lung » transl dunja (Expandir a Pesquisa), cranial lung (Expandir a Pesquisa)
cancer read » cancer real (Expandir a Pesquisa), cancer spread (Expandir a Pesquisa), cancer renal (Expandir a Pesquisa)
cancer res » cancer re (Expandir a Pesquisa), cancer real (Expandir a Pesquisa), cancer result (Expandir a Pesquisa)
A mostrar 421 - 440 resultados de 1,782 para a pesquisa '((transl lung) OR (transoral lung)) ((cancer res) OR (((cancer read) OR (cancer ready))))', tempo de pesquisa: 5.01seg Refinar resultados
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role
Managing screening-detected subsolid nodules—the Asian perspective

Influence of chemotherapy on EGFR mutation status
Gefitinib in non-small-cell lung cancer—an old lesson new re-visited

Managing of screening-detected sub-solid nodules—a European perspective
The person behind the nodule: a narrative review of the psychological impact of lung cancer screening

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)
Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI)

Shashen maidong decoction: the effect of TNF-α and IL-6 on lung cancer cachexia based on cancer toxicity theory
Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database

Immunotherapy in tyrosine kinase inhibitor-naïve advanced epidermal growth factor receptor-mutant non-small cell lung cancer—driving down a precarious road in driver-mutated lung cancer
Empiric Radiotherapy for Lung Cancer Collaborative Group multi-institutional evidence-based guidelines for the use of empiric stereotactic body radiation therapy for non-small cell lung cancer without pathologic confirmation

Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer
Tumor lymphocytic infiltration in non-small cell lung cancer: the ultimate prognostic marker?

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer
Professor Robert Pirker: primary prevention and early detection of lung cancer should be strengthened

KEYNOTE-028: how do we use immunotherapy in small cell lung cancer?
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa